SHREVEPORT, La. - Ochsner LSU Health Shreveport is one of only 40 hospitals nationwide selected for a new American Heart ...
In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...
Please provide your email address to receive an email when new articles are posted on . Among patients undergoing high-risk PCI with mechanical circulatory support who survived to 90 days without ...
MedPage Today on MSN
FDA panel on interatrial shunt for heart failure: It's a hard no
An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.
San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...
OR YEHUDA, Israel, Nov. 26, 2025 /PRNewswire/ -- Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback